128 related articles for article (PubMed ID: 11564069)
1. Results of autologous stem cell transplant in multiple myeloma patients with renal failure.
Badros A; Barlogie B; Siegel E; Roberts J; Langmaid C; Zangari M; Desikan R; Shaver MJ; Fassas A; McConnell S; Muwalla F; Barri Y; Anaissie E; Munshi N; Tricot G
Br J Haematol; 2001 Sep; 114(4):822-9. PubMed ID: 11564069
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study.
Sarosiek S; Lee MH; Doros G; Edwards CV; Quillen K; Brauneis D; Shelton AC; Sanchorawala V; Sloan JM
Transplant Cell Ther; 2023 Nov; 29(11):695.e1-695.e7. PubMed ID: 37607644
[TBL] [Abstract][Full Text] [Related]
3. Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis.
Wei M; Xie C; Huang J; Liu Q; Lai Y
Hematology; 2023 Dec; 28(1):2269509. PubMed ID: 37850613
[TBL] [Abstract][Full Text] [Related]
4. Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis.
Yadav N; Mirgh SP; Aggarwal M; Agrawal N; Mehta P; Khushoo V; Kapoor J; Bhatia N; Agrawal P; Ahmed R; Bhurani D
Indian J Cancer; 2023; 60(3):316-324. PubMed ID: 37787191
[TBL] [Abstract][Full Text] [Related]
5. High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.
Pineda-Roman M; Barlogie B; Anaissie E; Zangari M; Bolejack V; van Rhee F; Tricot G; Crowley J
Cancer; 2008 Apr; 112(8):1754-64. PubMed ID: 18300230
[TBL] [Abstract][Full Text] [Related]
6. Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115.
Sanchorawala V; Hoering A; Seldin DC; Finn KT; Fennessey SA; Sexton R; Mattar B; Safah HF; Holmberg LA; Dean RM; Orlowski RZ; Barlogie B
Bone Marrow Transplant; 2013 Nov; 48(12):1537-42. PubMed ID: 23852321
[TBL] [Abstract][Full Text] [Related]
7. Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
Garderet L; Ouldjeriouat H; Bekadja MA; Daguenet E; Bigot N; Vincent L; Roos-Weil D; Vignon M; Ikhlef S; Abraham J; Escoffre-Barbe M; Lioure B; Nacer RA; Lafon I; Mariette C; Karlin L; Morel P; Gilis L; Le Ray E; Blouet A; Nguyen Quoc S; Boffa JJ; Ronco P; Lambert J; Cornillon J
Br J Haematol; 2024 Apr; 204(4):1450-1458. PubMed ID: 37953476
[TBL] [Abstract][Full Text] [Related]
8. Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.
Rath C; Yoo C; Cheplowitz H; Lo M; Young R; Guglielmo J; Saunders IM; Banerjee R; Young R; Kumar A; Chung A; Rosenberg AS; Costello C; Fine J; Wilson M; Patel N; Banez MT
J Oncol Pharm Pract; 2023 Oct; 29(7):1715-1724. PubMed ID: 36731514
[TBL] [Abstract][Full Text] [Related]
9. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.
Rodríguez-Lobato LG; Martínez-Roca A; Castaño-Díez S; Palomino-Mosquera A; Gutiérrez-García G; Pedraza A; Suárez-Lledó M; Rovira M; Martínez C; Fernández de Larrea C; Cibeira MT; Rosiñol L; Lozano E; Marín P; Cid J; Lozano M; Moreno-Castaño AB; Palomo M; Díaz-Ricart M; Gallego C; Hernando A; Segura S; Carreras E; Urbano-Ispizua Á; Bladé J; Fernández-Avilés F
PLoS One; 2020; 15(11):e0241778. PubMed ID: 33147257
[TBL] [Abstract][Full Text] [Related]
10. Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis.
Li H; Zheng Y; Gao K; Tian C
Hematology; 2024 Dec; 29(1):2343164. PubMed ID: 38651865
[TBL] [Abstract][Full Text] [Related]
11. Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.
Richter S; Böttcher M; Stoll A; Zeremski V; Völkl S; Mackensen A; Ekici AB; Jacobs B; Mougiakakos D
Transplant Cell Ther; 2024 Jun; 30(6):628.e1-628.e9. PubMed ID: 38460727
[TBL] [Abstract][Full Text] [Related]
12. Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma.
Zhang Y; Rose A; Khadka S; Cao B; Eatrides J; Saeed H; Shah BD; Chavez J; Bello C; Lazaryan A; Khimani F; Ibarz JP; Liu HD; Locke FL; Jain MD; Zhang L; Kharfan-Dabaja MA; Kim J; Ayala E; Nishihori T; Sokol L
Transplant Cell Ther; 2024 May; ():. PubMed ID: 38740140
[TBL] [Abstract][Full Text] [Related]
13. Incident hyperglycemia, parenteral nutrition administration and adverse outcomes in patients with myeloma admitted for initial auto-SCT.
Sheean PM; Kilkus JM; Liu D; Maciejewski J; Braunschweig CA
Bone Marrow Transplant; 2013 Aug; 48(8):1117-22. PubMed ID: 23419432
[TBL] [Abstract][Full Text] [Related]
14. Role of Stem Cell Transplantation in Multiple Myeloma.
Devarakonda S; Efebera Y; Sharma N
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670709
[TBL] [Abstract][Full Text] [Related]
15. High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
Varga C; Comenzo RL
Bone Marrow Transplant; 2019 Apr; 54(4):508-518. PubMed ID: 30089901
[TBL] [Abstract][Full Text] [Related]
16. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
[TBL] [Abstract][Full Text] [Related]
17. Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study.
Soloveva M; Solovev M; Mironova D; Mendeleeva L
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):64-74. PubMed ID: 38680711
[No Abstract] [Full Text] [Related]
18. Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis.
Cook RJ; Wang Z; Arora M; Lazarus HM; Kasow KA; Champagne MA; Saber W; van Besien KM; Hale GA; Copelan EA; Elmongy M; Ueno NT; Horn BN; Slavin S; Bishop MR; Stadtmauer EA
Bone Marrow Transplant; 2012 Nov; 47(11):1455-8. PubMed ID: 22465977
[TBL] [Abstract][Full Text] [Related]
19. Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
Lum LG; Thakur A; Kondadasula SV; Al-Kadhimi Z; Deol A; Tomaszewski EN; Yano H; Schalk DL; Ayash L; Zonder JA; Uberti JP; Abidi MH; Ratanatharathorn V
Biol Blood Marrow Transplant; 2016 May; 22(5):869-78. PubMed ID: 26827660
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma with chronic kidney disease dependent on peritoneal dialysis and autologous stem cell transplant.
Tyszkiewicz A; Heras Benito M; Urzola Rodriguez G; Rey Búa B; Baile González M; Sánchez-Jáuregui Castillo M
Nefrologia (Engl Ed); 2020 Nov; ():. PubMed ID: 33246783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
